(Q43880095)

English

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.

scientific article published on 14 January 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Stefan Schönland

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Monique C Minnema

1

object named as

M C Minnema

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

object named as

S Zweegman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Niels W C J van de Donk

2

object named as

N W C J van de Donk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Henk M. Lokhorst

10

object named as

H M Lokhorst

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

U Hegenbart

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

R Raymakers

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J M J M Zijlmans

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M J Kersten

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

G M J Bos

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

0 references

publication date

14 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

779-784

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195681%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

21 January 2018

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705982

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43880095&oldid=2206311655"